Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Royalty Pharma Plc Cl A 110 East 59th New York NY 10022 USA

P: 212-883-0200

Description:

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 24,153,462
Shares Outstanding, K 607,176
Annual Sales, $ 2,289 M
Annual Net Income, $ 619,730 K
Last Quarter Sales, $ 562,050 K
Last Quarter Net Income, $ 51,760 K
60-Month Beta 0.36
% of Insider Shareholders 25.86%
% of Institutional Shareholders 51.68%
Float, K 450,160
% Float 74.14%

Growth:

1-Year Return -2.66%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.61 on 05/05/22
Next Earnings Date N/A
Earnings Per Share ttm 2.85
EPS Growth vs. Prev Qtr -23.75%
EPS Growth vs. Prev Year -8.96%
Annual Dividend Rate, $ 0.76
Annual Dividend Yield 1.88%
Most Recent Dividend 0.190 on 05/19/22
Next Ex-Dividends Date 05/19/22
Dividend Payable Date 06/15/22
Dividend Payout Ratio 24.64%

RPRX Ratios

Ratio
Price/Earnings ttm 14.21
Price/Earnings forward 13.54
Price/Earnings to Growth 1.11
Return-on-Equity % 16.75%
Return-on-Assets % 9.98%
Profit Margin % 27.07
Net Margin % N/A
Debt/Equity 0.69
Price/Sales 10.75
Price/Cash Flow 13.59
Price/Book 2.43
Book Value/Share 16.70
Interest Coverage 8.47

RPRX Dividends

Date Value
05/19/22 $0.1900
02/17/22 $0.1900
11/18/21 $0.1700
08/19/21 $0.1700
05/19/21 $0.1700
02/18/21 $0.1700
11/19/20 $0.1500
09/14/20 $0.1500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar